MBZUAI unveils the Institute of Digital Public Health, harnessing AI foundation models and a data-driven approach to drive innovation across computational biology, precision medicine, infectious disease monitoring, and the UAE Genome Atlas for transformative public health solutions.
Researchers have developed a groundbreaking method combining test-time augmentation and conformal prediction, enhancing AI model reliability by up to 30% for critical tasks like medical diagnosis, enabling more accurate and efficient decision-making in high-stakes scenarios.
Tempus AI unveils groundbreaking $200M deals with AstraZeneca and Pathos AI to build the largest AI model in oncology, harnessing multimodal data to drive biological insights, drug target discovery, and therapeutic development for cancer patients.
In a groundbreaking development, researchers have harnessed the power of AI and machine learning to analyze patient data, enabling the prediction of Alzheimer's disease up to 7 years before symptoms manifest, with high cholesterol and osteoporosis emerging as key predictors.
Breakthrough AI tools developed by Cambridge researchers can accurately predict cystic fibrosis progression, enabling personalized treatment plans tailored to individual patients' disease trajectories, competing health risks, and past cases, representing a major step towards precision healthcare.
In a groundbreaking development, the FDA has approved a key component of Precision Neuroscience's brain implant system, paving the way for paralyzed patients to potentially regain speech and movement through a cutting-edge brain-computer interface technology that rivals efforts by Neuralink, Synchron, and other prominent players.
Scientists developed a starfish-shaped wearable device that leverages AI to precisely track heart health in real time with over 90% accuracy, even during movement, enabling comfortable long-term at-home monitoring with wireless charging and skin-friendly materials.
An AI algorithm trained on 80,000 cases optimizes intravenous nutrition for premature babies, reducing medical errors and costs while enhancing care efficiency and accessibility by assisting doctors in making better clinical decisions for this vulnerable population.
Amazon is pushing into generative AI with new conversational shopping and health assistants, including 'Interests AI' for product recommendations and a chatbot offering medical advice and wellness guidance.
Ant Group strategically combines Chinese and U.S. semiconductors for cost-effective AI development, enhancing its healthcare solutions by leveraging a 'mixture of experts' technique, with upgraded AI models being adopted by major Chinese hospitals.